glp-1 drugs eli lilly The Food and Drug Administration has approved the first oral weight loss drug by Lilly, called Foundayo GLP-1 weight loss could soon

Researchers using a national database of health care providers on the electronic medical record Epic found no evidence of excess risk of thyroid cancer

Many individuals continue to prefer an injectable option, particularly when it better aligns with their routine or expectations

Back Pollack, A (21 Sept 2002) 'Lizard-linked therapy has roots in the Bronx', The New York Times

The ongoing SURPASS-CVOT study, which is evaluating the impact of tirzepatide on CV events in an active comparator trial with dulaglutide (Trulicity, Eli Lilly), may help to define the role of that agent in CV prevention for people with type 2 diabetes

That meant no dangerous sugar crashes, a common problem with some older diabetes drugs